Array BioPharma Inc. - Product Pipeline Review - 2015

Date: November 18, 2015
Pages: 68
Price:
US$ 1,500.00 US$ 1,275.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A2A8FA832C8EN
Leaflet:

Download PDF Leaflet

Array BioPharma Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Array BioPharma Inc. - Product Pipeline Review - 2015’, provides an overview of the Array BioPharma Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Array BioPharma Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of Array BioPharma Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Array BioPharma Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Array BioPharma Inc.’s pipeline products
Reasons to buy
  • Evaluate Array BioPharma Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Array BioPharma Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Array BioPharma Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Array BioPharma Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Array BioPharma Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Array BioPharma Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Array BioPharma Inc. Snapshot
Array BioPharma Inc. Overview
Key Information
Key Facts
Array BioPharma Inc. - Research and Development Overview
Key Therapeutic Areas
Array BioPharma Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Array BioPharma Inc. - Pipeline Products Glance
Array BioPharma Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Array BioPharma Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Array BioPharma Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Array BioPharma Inc. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
Array BioPharma Inc. - Drug Profiles
binimetinib
Product Description
Mechanism of Action
R&D Progress
binimetinib + encorafenib
Product Description
Mechanism of Action
R&D Progress
encorafenib
Product Description
Mechanism of Action
R&D Progress
filanesib
Product Description
Mechanism of Action
R&D Progress
ARRY-502
Product Description
Mechanism of Action
R&D Progress
ARRY-797
Product Description
Mechanism of Action
R&D Progress
pexmetinib
Product Description
Mechanism of Action
R&D Progress
AR-460770
Product Description
Mechanism of Action
R&D Progress
AR-523
Product Description
Mechanism of Action
R&D Progress
AR-786
Product Description
Mechanism of Action
R&D Progress
ARRY-981
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Inflammation
Product Description
Mechanism of Action
R&D Progress
AR-00457679
Product Description
Mechanism of Action
R&D Progress
ARRY-111
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Kinase for Autoimmune Disorders
Product Description
Mechanism of Action
R&D Progress
Array BioPharma Inc. - Pipeline Analysis
Array BioPharma Inc. - Pipeline Products by Target
Array BioPharma Inc. - Pipeline Products by Route of Administration
Array BioPharma Inc. - Pipeline Products by Molecule Type
Array BioPharma Inc. - Pipeline Products by Mechanism of Action
Array BioPharma Inc. - Recent Pipeline Updates
Array BioPharma Inc. - Dormant Projects
Array BioPharma Inc. - Dormant Projects
Array BioPharma Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ARRY-797
Array BioPharma Inc. - Company Statement
Array BioPharma Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Array BioPharma Inc., Key Information
Array BioPharma Inc., Key Facts
Array BioPharma Inc. - Pipeline by Indication, 2015
Array BioPharma Inc. - Pipeline by Stage of Development, 2015
Array BioPharma Inc. - Monotherapy Products in Pipeline, 2015
Array BioPharma Inc. - Combination Treatment Modalities in Pipeline, 2015
Array BioPharma Inc. - Partnered Products in Pipeline, 2015
Array BioPharma Inc. - Partnered Products/ Combination Treatment Modalities, 2015
Array BioPharma Inc. - Out-Licensed Products in Pipeline, 2015
Array BioPharma Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Array BioPharma Inc. - Phase III, 2015
Array BioPharma Inc. - Phase II, 2015
Array BioPharma Inc. - Phase I, 2015
Array BioPharma Inc. - Preclinical, 2015
Array BioPharma Inc. - Discovery, 2015
Array BioPharma Inc. - Unknown, 2015
Array BioPharma Inc. - Pipeline by Target, 2015
Array BioPharma Inc. - Pipeline by Route of Administration, 2015
Array BioPharma Inc. - Pipeline by Molecule Type, 2015
Array BioPharma Inc. - Pipeline Products by Mechanism of Action, 2015
Array BioPharma Inc. - Recent Pipeline Updates, 2015
Array BioPharma Inc. - Dormant Developmental Projects,2015
Array BioPharma Inc. - Discontinued Pipeline Products, 2015
Array BioPharma Inc., Other Locations

LIST OF FIGURES

Array BioPharma Inc. - Pipeline by Top 10 Indication, 2015
Array BioPharma Inc. - Pipeline by Stage of Development, 2015
Array BioPharma Inc. - Monotherapy Products in Pipeline, 2015
Array BioPharma Inc. - Combination Treatment Modalities in Pipeline, 2015
Array BioPharma Inc. - Partnered Products in Pipeline, 2015
Array BioPharma Inc. - Out-Licensed Products in Pipeline, 2015
Array BioPharma Inc. - Pipeline by Top 10 Target, 2015
Array BioPharma Inc. - Pipeline by Top 10 Route of Administration, 2015
Array BioPharma Inc. - Pipeline by Top 10 Molecule Type, 2015
Array BioPharma Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Skip to top


Ask Your Question

Array BioPharma Inc. - Product Pipeline Review - 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: